Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.450

-2.5%

9:56 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (155)	4/5/2005 1:00:38 AM
From: tuck	of 368

Thanks, though SCID is a small market, and the solution may not be as "general" as Sangamo would have you believe. Cancer, for example, is often thought of as a microscale exercise in Darwinian evolution, in which mutated cells achieve a selective advantage over normal cells and proliferate exponentially. pubmedcentral.nih.gov So cancer seems like a tougher task. SCID is low hanging fruit for gene therapy (though it's been tough to pick, even so, as demonstrated by the off target effects resulting in leukemia for several children in a french study that was in fact curing them of SCID), but not certainly not the sweetest one. Don't get me wrong, it's good news, but until it can show promise in other more common diseases, I'm not going to get too excited. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next